Effect of surfactants or a water soluble polymer on the crystal transition of clarithromycin during a wet granulation process.

[1]  S. Itai,et al.  Suppressed Release of Clarithromycin from Tablets by Crystalline Phase Transition of Metastable Polymorph Form I. , 2015, Journal of pharmaceutical sciences.

[2]  Keiko Takiyama,et al.  Polymorphic transformation of antibiotic clarithromycin under acidic condition. , 2014, Journal of pharmaceutical sciences.

[3]  J. V. D. Streek.  Reinterpretation of the monohydrate of clarithromycin from X-ray powder diffraction data as a trihydrate. , 2012 .

[4]  S. Itai,et al.  Clarithromycin form I determined by synchrotron X-ray powder diffraction. , 2012, Acta crystallographica. Section C, Crystal structure communications.

[5]  S. Itai,et al.  Stabilization mechanism of clarithromycin tablets under gastric pH conditions. , 2011, Chemical & pharmaceutical bulletin.

[6]  J. Atwood,et al.  A new strategy of transforming pharmaceutical crystal forms. , 2011, Journal of the American Chemical Society.

[7]  S. Wimperis,et al.  Solid-state NMR spectroscopy. , 2009, Physical chemistry chemical physics : PCCP.

[8]  N. Rodríguez-Hornedo,et al.  Surfactant-facilitated crystallization of dihydrate carbamazepine during dissolution of anhydrous polymorph. , 2004, Journal of pharmaceutical sciences.

[9]  T. Oguchi,et al.  Characterization and quantitation of clarithromycin polymorphs by powder X-ray diffractometry and solid-state NMR spectroscopy. , 2002, Chemical & pharmaceutical bulletin.

[10]  Y. Kawashima,et al.  Method of evaluation of the bitterness of clarithromycin dry syrup. , 2002, Chemical & pharmaceutical bulletin.

[11]  M. Parvez,et al.  Clarithromycin hydro­chloride 3.5‐hydrate , 2000 .

[12]  Y. Sohn,et al.  Polymorphism of clarithromycin , 2000, Archives of pharmacal research.

[13]  John Magee,et al.  The Method of Evaluation , 2000 .

[14]  T. Yajima,et al.  Optimum spray congealing conditions for masking the bitter taste of clarithromycin in wax matrix. , 1999, Chemical & pharmaceutical bulletin.

[15]  Yoshiaki Watanabe,et al.  Structure of 6‐O‐methylerythromycin A (clarithromycin) , 1993 .

[16]  T. Nagai,et al.  Physicochemical properties and stability in the acidic solution of a new macrolide antibiotic, clarithromycin, in comparison with erythromycin. , 1992, Chemical & pharmaceutical bulletin.

[17]  Yoshiaki Watanabe,et al.  Chemical modification of erythromycins. VI. Structure and antibacterial activity of acid degradation products of 6-O-methylerythromycins A. , 1990, The Journal of antibiotics.